McDavid Stilwell - Dec 31, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Financial Officer
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for McDavid Stilwell
Stock symbol
CHRS
Transactions as of
Dec 31, 2023
Transactions value $
-$61,405
Form type
4
Date filed
1/3/2024, 04:42 PM
Previous filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$61.4K -18.4K -19.67% $3.33 75.3K Dec 31, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
F2 Includes 4,826 shares acquired on November 15, 2023, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan and includes the cancellation of 13,333 restricted stock units.